This fall, BMC2 will launch REMIND-DM. This project will evaluate the effectiveness of targeted provider education and the implementation of a reminder embedded within cardiac catheterization reports. We hope to better understand the effectiveness of this approach on improving education and prescribing around medications that have demonstrated benefit among patients with diabetes who also have coronary artery disease.
Participation in REMIND-DM is voluntary, low-cost, and easy to implement. The project design does not mandate any changes to patient care delivery, and the evaluation will use data our sites are already collecting. BMC2 will kick off REMIND-DM mid-November and the evaluation will continue into the spring of 2023.
We appreciate the engagement and willingness to learn shown by those who signed up to participate in REMIND-DM. Enrollment is closed at this time. We look forward to exploring new ways to drive quality improvement and will share our findings with the consortium in the coming year.